These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18937726)

  • 1. A case report of plasma exchange, steroids, mycophenolate mofetil and cyclophosphamide in acquired factor VIII inhibitors.
    Rech J; Hueber AJ; Leipe J; Manger B; Schett G; Kallert S
    Ther Apher Dial; 2008 Oct; 12(5):406-8. PubMed ID: 18937726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful long-time treatment with mycophenolate-mofetil in a child with acquired factor VIII inhibitor.
    Wermes C; Niekrens C; Sykora KW
    Hamostaseologie; 2012; 32 Suppl 1():S75-8. PubMed ID: 22961096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid decrease in high titer of factor VIII inhibitors upon immunosuppressive treatment in severe postpartum acquired hemophilia A.
    Pejsa V; Grgurević I; Kusec R; Gaćina P
    Croat Med J; 2004 Apr; 45(2):213-6. PubMed ID: 15103761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired hemophilia A in a woman with systemic lupus erythematosus: A case report and review of literature.
    Shen P; Li J; Tu S; Chen G; Chen C
    Medicine (Baltimore); 2020 Oct; 99(43):e22926. PubMed ID: 33120848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L; Pitlik E
    Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P; Plamenová I; Hollý P; Stasko J
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tipping point: The critical role of therapeutic apheresis in a case of refractory acquired hemophilia.
    Losos M; Scrape S; Joshi S; Shmookler A; Chen J
    J Clin Apher; 2017 Dec; 32(6):564-566. PubMed ID: 27646211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Refractory acquired hemophilia A in which factor VIII inhibitor was not detected at onset and thereafter deteriorated after total hip replacement arthroplasty].
    Tanaka H; Yokota A; Onoda M; Uehara T; Terano T
    Rinsho Ketsueki; 2008 Nov; 49(11):1548-51. PubMed ID: 19047786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acquired factor VIII hemophilia in a geriatric patient].
    Boddi W; Machetti S; Sodi N; Sammicheli L; Cati G; Marotta G; Sabatini L; Cappelli R
    Ann Ital Med Int; 2005; 20(3):192-6. PubMed ID: 16250186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma exchange for acquired hemophilia: a case report.
    Ogata H; Sakai S; Koiwa F; Tayama H; Kinugasa E; Ideura T; Akizawa T
    Ther Apher; 1999 Nov; 3(4):320-2. PubMed ID: 10608727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of hemophilic FVIII inhibitors with FVIII priming, cyclophosphamide immune suppression, and rapid tapering of FVIII immune tolerance.
    Kobrinsky NL; Sjolander DE; Moser DK; Stegman DA
    Am J Hematol; 2004 Jun; 76(2):180-4. PubMed ID: 15164387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis and laboratory findings in a patient with acquired hemophilia A].
    Xie BS; Wang WQ; Huang Y; Ye LL; Hu LM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):206-8. PubMed ID: 19236780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systemic lupus erythematosus with acquired hemophilia A: a case report].
    Yang F; Zhou YS; Jia Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1108-1111. PubMed ID: 30562791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.
    Ong LM; Hooi LS; Lim TO; Goh BL; Ahmad G; Ghazalli R; Teo SM; Wong HS; Tan SY; Shaariah W; Tan CC; Morad Z
    Nephrology (Carlton); 2005 Oct; 10(5):504-10. PubMed ID: 16221103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired hemophilia A: report of two cases.
    Chen YC; Chang JY; Hsueh EJ; Wan HL; Chao TY
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Sep; 61(9):538-44. PubMed ID: 9798303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exchange transfusion and pulse steroid therapy in a hemophiliac with inhibitor.
    Chuansumrit A; Isarangkura P; Krutvecho T; Hathirat P; Pintadit P
    J Med Assoc Thai; 1989 Jan; 72 Suppl 1():139-43. PubMed ID: 2499649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic plasma exchange as part of multimodal treatment of acquired hemophilia in a patient with concurrent acute intracerebral bleed and pulmonary embolism.
    Wool GD; Chapel D; Treml A; Miller JL
    Transfusion; 2017 Jul; 57(7):1827-1832. PubMed ID: 28436106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spontaneous hematomas and isolated prolongation of aPTT].
    Heimgartner B; Oestmann A; Keller P; Rüsges-Wolter I
    Praxis (Bern 1994); 2011 May; 100(10):603-6. PubMed ID: 21563098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of factor VIII inhibitor-positive acquired hemophilia treated by plasmapheresis.
    Narukawa N; Abe T; Shouno M; Kitabata Y; Okamoto M; Kobata H; Akizawa T
    Ther Apher; 1999 Nov; 3(4):323-5. PubMed ID: 10608728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.